What is the recommended dosing for Ativan (lorazepam) in managing alcohol withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lorazepam Dosing for Alcohol Withdrawal

For alcohol withdrawal syndrome, lorazepam should be administered at 1-4 mg PO/IV/IM every 4-8 hours as needed, with symptom-triggered dosing being the preferred approach for most patients. 1

Dosing Approach

Symptom-Triggered Dosing (Preferred Method)

  • Use CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol-revised) scale to guide dosing
  • Categorize withdrawal severity:
    • Mild: CIWA-Ar <8
    • Moderate: CIWA-Ar 8-14
    • Severe: CIWA-Ar ≥15 1
  • Administer lorazepam only when symptoms appear (CIWA-Ar ≥8)
  • Benefits of symptom-triggered approach:
    • Significantly reduces total medication required (average 37.5 mg vs 231.4 mg with fixed schedule) 2
    • Shorter duration of treatment (20 hours vs 62.7 hours) 2
    • Equally effective for symptom control 2

Fixed-Schedule Dosing

  • Consider for patients with:
    • History of severe withdrawal
    • Seizures
    • Delirium tremens
    • Inability to reliably report symptoms
  • Initial dose: 2-4 mg every 6 hours
  • Additional doses as needed based on symptoms 1

Special Considerations

Liver Dysfunction

  • Lorazepam is preferred over long-acting benzodiazepines like diazepam or chlordiazepoxide in patients with:
    • Liver dysfunction
    • Advanced age
    • Respiratory compromise 1
  • Advantages of lorazepam:
    • Shorter half-life
    • No active metabolites
    • Less accumulation in hepatic impairment 3, 4

Dosing Adjustments

  • Start at lower doses (1-2 mg) for:
    • Elderly patients
    • Patients with hepatic impairment
    • Low body weight
  • Higher initial doses (3-4 mg) may be needed for:
    • Severe withdrawal
    • History of seizures
    • High tolerance to alcohol

Monitoring and Tapering

  • Assess withdrawal symptoms using CIWA-Ar scale every 1-2 hours initially
  • Once stabilized (CIWA-Ar <8), assess every 4-8 hours
  • Taper dose over 3-5 days to prevent rebound symptoms
  • Monitor for side effects:
    • Sedation
    • Respiratory depression
    • Dizziness (more common with lorazepam than chlordiazepoxide) 4
    • Motor incoordination (occurs in approximately 20% of patients) 5

Adjunctive Treatments

  • Thiamine supplementation (100-300 mg/day IV or PO) to prevent Wernicke encephalopathy 1
  • Electrolyte replacement (particularly magnesium, potassium, phosphate)
  • Adequate hydration 1

Potential Pitfalls

  • Avoid abrupt discontinuation which may precipitate withdrawal symptoms
  • Be aware that approximately 20% of patients may experience dizziness, motor incoordination, or ataxia without recognizing their impairment 5
  • Monitor for paradoxical agitation (occurs in approximately 10% of patients) 1
  • Avoid using lorazepam as the sole treatment for preventing relapse; consider acamprosate, naltrexone, or baclofen for relapse prevention after detoxification 1

Lorazepam has been shown to be as effective as chlordiazepoxide in managing alcohol withdrawal symptoms, with the advantage of being safer in patients with liver dysfunction 3, 4. The symptom-triggered approach is strongly recommended as it leads to lower total medication use and shorter treatment duration while maintaining efficacy 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.